close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PeptiDream Inc.

News headline image
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream, PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
From PeptiDream Inc.
Via Business Wire
News headline image
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Second Internal Peptide Radiopharmaceutical Therapeutic Program Targeting Claudin 18.2 for the Potential Diagnosis and Treatment of Gastric Cancer
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Preclinical Results Demonstrating Efficacy of Oral Myostatin Inhibitors in Preventing Loss of Lean Mass Associated with Semaglutide Treatment
From PeptiDream Inc.
Via Business Wire
News headline image
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Collaboration and License Agreement with Genentech for the Discovery and Development of Novel Peptide-Radioisotope Drug Conjugates
From PeptiDream Inc.
Via Business Wire
News headline image
Astellas and PeptiDream Enter into Research Collaboration and License Agreement to Discover Novel Targeted Protein Degraders
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Nomination of Second Peptide Radiopharmaceutical Therapeutic Development Candidate
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
From PeptiDream Inc.
Via Business Wire
News headline image
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
From PeptiDream Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today